These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 28122457)

  • 1. Idiopathic Pulmonary Fibrosis: Current Status, Recent Progress, and Emerging Targets.
    Liu YM; Nepali K; Liou JP
    J Med Chem; 2017 Jan; 60(2):527-553. PubMed ID: 28122457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation and immunity in IPF pathogenesis and treatment.
    Heukels P; Moor CC; von der Thüsen JH; Wijsenbeek MS; Kool M
    Respir Med; 2019 Feb; 147():79-91. PubMed ID: 30704705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic targets in idiopathic pulmonary fibrosis.
    Kolb M; Bonella F; Wollin L
    Respir Med; 2017 Oct; 131():49-57. PubMed ID: 28947042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idiopathic pulmonary fibrosis: current treatment options and critical appraisal of nintedanib.
    Bonella F; Stowasser S; Wollin L
    Drug Des Devel Ther; 2015; 9():6407-19. PubMed ID: 26715838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medications for Idiopathic Pulmonary Fibrosis: IPF Part 2.
    Guler SA; Lindell KO; Swigris J; Ryerson CJ
    Am J Respir Crit Care Med; 2021 Feb; 203(3):P7-P8. PubMed ID: 33522880
    [No Abstract]   [Full Text] [Related]  

  • 6. The earlier, the better: Impact of early diagnosis on clinical outcome in idiopathic pulmonary fibrosis.
    Aiello M; Bertorelli G; Bocchino M; Chetta A; Fiore-Donati A; Fois A; Marinari S; Oggionni T; Polla B; Rosi E; Stanziola A; Varone F; Sanduzzi A
    Pulm Pharmacol Ther; 2017 Jun; 44():7-15. PubMed ID: 28257817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent evidence for pharmacological treatment of idiopathic pulmonary fibrosis.
    Covvey JR; Mancl EE
    Ann Pharmacother; 2014 Dec; 48(12):1611-9. PubMed ID: 25202034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An update on emerging drugs for the treatment of idiopathic pulmonary fibrosis.
    Aryal S; Nathan SD
    Expert Opin Emerg Drugs; 2018 Jun; 23(2):159-172. PubMed ID: 29718783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pirfenidone: antifibrotic agent for idiopathic pulmonary fibrosis.
    Azuma A
    Expert Rev Respir Med; 2010 Jun; 4(3):301-10. PubMed ID: 20524912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antifibrotic therapy and progressive lung fibrosis].
    Fellrath JM
    Rev Med Suisse; 2020 Jun; 16(698):1256-1260. PubMed ID: 32558455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiopathic pulmonary fibrosis in the era of antifibrotic therapy: Searching for new opportunities grounded in evidence.
    Robalo-Cordeiro C; Campos P; Carvalho L; Borba A; Clemente S; Freitas S; Furtado S; Jesus JM; Leal C; Marques A; Melo N; Souto-Moura C; Neves S; Sousa V; Santos A; Morais A
    Rev Port Pneumol (2006); 2017; 23(5):287-293. PubMed ID: 28668400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Novel therapies for idiopathic pulmonary fibrosis].
    Wand O; Kremer MR
    Harefuah; 2015 Jul; 154(7):446-50, 469, 468. PubMed ID: 26380465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current and Future Idiopathic Pulmonary Fibrosis Therapy.
    Richeldi L; Baldi F; Pasciuto G; Macagno F; Panico L
    Am J Med Sci; 2019 May; 357(5):370-373. PubMed ID: 31010462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developments in the management of idiopathic pulmonary fibrosis.
    Drug Ther Bull; 2015 Jul; 53(7):78-81. PubMed ID: 26159700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is personalised medicine the key to heterogeneity in idiopathic pulmonary fibrosis?
    Clarke DL; Murray LA; Crestani B; Sleeman MA
    Pharmacol Ther; 2017 Jan; 169():35-46. PubMed ID: 27612548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiopathic Pulmonary Fibrosis: New and Emerging Treatment Options.
    Hewitt RJ; Maher TM
    Drugs Aging; 2019 Jun; 36(6):485-492. PubMed ID: 30864023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiopathic pulmonary fibrosis: the turning point is now!
    Funke M; Geiser T
    Swiss Med Wkly; 2015; 145():w14139. PubMed ID: 26024356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Advances and Future Needs in Interstitial Lung Diseases.
    Jones MG; Richeldi L
    Semin Respir Crit Care Med; 2016 Jun; 37(3):477-84. PubMed ID: 27231869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging therapeutic interventions for idiopathic pulmonary fibrosis.
    Chakraborty S; Chopra P; Ambi SV; Dastidar SG; Ray A
    Expert Opin Investig Drugs; 2014 Jul; 23(7):893-910. PubMed ID: 24766571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pirfenidone for the treatment of idiopathic pulmonary fibrosis.
    Xaubet A; Serrano-Mollar A; Ancochea J
    Expert Opin Pharmacother; 2014 Feb; 15(2):275-81. PubMed ID: 24308635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.